Home | Life Sciences | Search


"We highly appreciate the willingness of Wellington Partners to invest in our company. Thanks to their excellent network, we will be able to accelerate our growth and to extend our corporate clients base."

Carlo Koelzer
CEO, 360T

Wellington contact:
Rolf Dienst

A decade of profitable growth

Two recessions, one global financial crisis – but 360T, founded in 2000, has managed to stay on a profitable growth course. The key to success in a turbulent decade has been its proprietary multi-bank, multi-asset trading platform which helps global players to cope with the ups and downs in the global foreign exchange and cash markets. Corporate treasuries, institutional clients (including asset managers and hedge funds), as well as brokers, dealers and banks use 360T’s platform to manage their foreign exchange exposure, as well as money market transactions and aligned derivatives.

The business concept to trade currencies quickly, efficiently, transparently and cheaply was developed in 2000 by founding partner and long-term CEO Carlo Koelzer, and his surrounding team. In the following years, the team executed its business plan step-by-step and continued to strengthen its management team. The commitment of Wellington Partners in early 2010 marked a new era for the German-based company: accelerated globalization. At this time, the company was already located in four financial hubs around the globe: Frankfurt, New York, Singapore and Dubai, and had customers in over 40 countries. With the support of Wellington Partners, 360T was able to extend its global footprint, particularly in the American and Far Eastern markets.

In early 2012, the company entered the next stage on its way to global success. Growth equity investor Summit Partners acquired a majority stake in 360T and enabled Wellington to realize another very successful exit.

Home | Wellington Tech | Investment Sectors | Our Team | Our Portfolio | News | Careers | Contact | Terms and Conditions
Facebook
Twitter
Xing
LinkedIn
Google
 © 1998- by Wellington Partners Venture Capital | Technology | Life Sciences